Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2146
Gene Symbol: EZH2
EZH2
0.030 AlteredExpression disease BEFREE "Oncogene-induced" and/or stress-induced senescence may occur in the process of multi-step cholangiocarcinogenesis, and overexpression of a polycomb group protein EZH2 may play a role in the escape from, and/or bypassing of, senescence. 26680649 2016
Entrez Id: 4161
Gene Symbol: MC5R
MC5R
0.010 Biomarker disease BEFREE <b>Conclusion:</b> The relative balance of reduced trigger and increased substrate underlies a multi-dimensional role of MC-II-157c in modulation of cardiac arrhythmia vulnerability associated with prolonged QT interval. 29046643 2017
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.050 Biomarker disease BEFREE <b>Purpose:</b> To investigate whether prebiopsy multi-parametric (mp) MRI can help to improve predictive performance in prostate cancer.<b>Experimental Design:</b> Based on a support vector machine (SVM) analysis, we prospectively modeled clinical data (age, PSA, digital rectal examination, transrectal ultrasound, PSA density, and prostate volume) and mp-MRI findings [Prostate Imaging and Reporting and Data System (PI-RADS) score and tumor-node-metastasis stage] in 985 men to predict the risk of prostate cancer. 28143868 2017
Entrez Id: 5324
Gene Symbol: PLAG1
PLAG1
0.040 Biomarker disease BEFREE <b>Purpose:</b> To investigate whether prebiopsy multi-parametric (mp) MRI can help to improve predictive performance in prostate cancer.<b>Experimental Design:</b> Based on a support vector machine (SVM) analysis, we prospectively modeled clinical data (age, PSA, digital rectal examination, transrectal ultrasound, PSA density, and prostate volume) and mp-MRI findings [Prostate Imaging and Reporting and Data System (PI-RADS) score and tumor-node-metastasis stage] in 985 men to predict the risk of prostate cancer. 28143868 2017
Entrez Id: 9520
Gene Symbol: NPEPPS
NPEPPS
0.040 Biomarker disease BEFREE <b>Purpose:</b> To investigate whether prebiopsy multi-parametric (mp) MRI can help to improve predictive performance in prostate cancer.<b>Experimental Design:</b> Based on a support vector machine (SVM) analysis, we prospectively modeled clinical data (age, PSA, digital rectal examination, transrectal ultrasound, PSA density, and prostate volume) and mp-MRI findings [Prostate Imaging and Reporting and Data System (PI-RADS) score and tumor-node-metastasis stage] in 985 men to predict the risk of prostate cancer. 28143868 2017
Entrez Id: 5627
Gene Symbol: PROS1
PROS1
0.040 Biomarker disease BEFREE <b>Purpose:</b> To investigate whether prebiopsy multi-parametric (mp) MRI can help to improve predictive performance in prostate cancer.<b>Experimental Design:</b> Based on a support vector machine (SVM) analysis, we prospectively modeled clinical data (age, PSA, digital rectal examination, transrectal ultrasound, PSA density, and prostate volume) and mp-MRI findings [Prostate Imaging and Reporting and Data System (PI-RADS) score and tumor-node-metastasis stage] in 985 men to predict the risk of prostate cancer. 28143868 2017
Entrez Id: 29968
Gene Symbol: PSAT1
PSAT1
0.040 Biomarker disease BEFREE <b>Purpose:</b> To investigate whether prebiopsy multi-parametric (mp) MRI can help to improve predictive performance in prostate cancer.<b>Experimental Design:</b> Based on a support vector machine (SVM) analysis, we prospectively modeled clinical data (age, PSA, digital rectal examination, transrectal ultrasound, PSA density, and prostate volume) and mp-MRI findings [Prostate Imaging and Reporting and Data System (PI-RADS) score and tumor-node-metastasis stage] in 985 men to predict the risk of prostate cancer. 28143868 2017
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.060 GeneticVariation disease BEFREE 'Non-classical' HER2 FISH results in breast cancer: a multi-institutional study. 27739440 2017
Entrez Id: 8291
Gene Symbol: DYSF
DYSF
0.020 Biomarker disease BEFREE Multi-Western blot analysis confirmed dysferlin deficiency of muscle specimen from the propositus. 16023782 2006
Entrez Id: 23158
Gene Symbol: TBC1D9
TBC1D9
0.100 GeneticVariation disease BEFREE Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia. 16382213 2006
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.100 GeneticVariation disease BEFREE Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia. 16382213 2006
Entrez Id: 7298
Gene Symbol: TYMS
TYMS
0.020 AlteredExpression disease BEFREE Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. 16584549 2006
Entrez Id: 114
Gene Symbol: ADCY8
ADCY8
0.010 GeneticVariation disease BEFREE Multi-locus analyses suggested joint effects between ADCY8 and ST3GAL1 (P = 3.00 x 10(-4)), with at least one copy of the "high risk" allele required at both genes for association with BP, consistent with a jointly dominant-dominant model of action. 18163389 2008
Entrez Id: 2539
Gene Symbol: G6PD
G6PD
0.010 GeneticVariation disease BEFREE Multi-mutational analysis of fifteen common mutations of the glucose 6-phosphate dehydrogenase gene in the Mediterrranean population. 18549810 2008
Entrez Id: 8626
Gene Symbol: TP63
TP63
0.010 AlteredExpression disease BEFREE Multi-dimensional scaling (MDS) analysis showed that the gene expression profiles of these four regions accurately distinguish GIST and LMS. 20218739 2010
Entrez Id: 2886
Gene Symbol: GRB7
GRB7
0.010 AlteredExpression disease BEFREE Multi-variate analysis revealed that GRB7 protein over-expression was an independent adverse prognostic factor for breast cancer-free interval (hazard ratio 1.69, 95% confidence interval 1.07-2.67; P = 0.024). 20635137 2011
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.020 GeneticVariation disease BEFREE Multi-SNP models explained R(2) = 0.62% of the variation in circulating IGF-I and 3.9% of the variation in circulating IGFBP-3. 20810604 2010
Entrez Id: 3486
Gene Symbol: IGFBP3
IGFBP3
0.010 GeneticVariation disease BEFREE Multi-SNP models explained R(2) = 0.62% of the variation in circulating IGF-I and 3.9% of the variation in circulating IGFBP-3. 20810604 2010
Entrez Id: 1025
Gene Symbol: CDK9
CDK9
0.020 Biomarker disease BEFREE Multi-labelling confocal laser-scanning microscopy revealed that CDK9 and cyclin T1 co-localized perfectly with pUL69 in individual speckles. 21450947 2011
Entrez Id: 904
Gene Symbol: CCNT1
CCNT1
0.010 Biomarker disease BEFREE Multi-labelling confocal laser-scanning microscopy revealed that CDK9 and cyclin T1 co-localized perfectly with pUL69 in individual speckles. 21450947 2011
Entrez Id: 969
Gene Symbol: CD69
CD69
0.010 AlteredExpression disease BEFREE Multi-parametric flow cytometry assessment of T cell activation (CD69, HLA-DR, CD38) and Treg frequency (CD25(+)FOXP3(+)) found no differences between genotype groups. 22214232 2012
Entrez Id: 5265
Gene Symbol: SERPINA1
SERPINA1
0.020 AlteredExpression disease BEFREE Multi-tissue gene expression studies identified variants in our top loci, SERPINA1 and AQP9, as eQTLs and showed that SERPINA1 and AQP9 expression in human blood was associated with metabolites from their corresponding metabolic networks. 22916037 2012
Entrez Id: 366
Gene Symbol: AQP9
AQP9
0.010 AlteredExpression disease BEFREE Multi-tissue gene expression studies identified variants in our top loci, SERPINA1 and AQP9, as eQTLs and showed that SERPINA1 and AQP9 expression in human blood was associated with metabolites from their corresponding metabolic networks. 22916037 2012
Entrez Id: 7498
Gene Symbol: XDH
XDH
0.010 GeneticVariation disease BEFREE Multi-exon deletion in the XDH gene as a cause of classical xanthinuria. 23249873 2013
Entrez Id: 302
Gene Symbol: ANXA2
ANXA2
0.020 AlteredExpression disease BEFREE Multi-variate Cox regression analysis revealed that annexin II expression level was an independent prognostic parameter for the overall survival rate of NSCLC patients. 23494179 2013